OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial
Karim Fizazi, Neal D. Shore, Matthew R. Smith, et al.
European Journal of Cancer (2023) Vol. 192, pp. 113258-113258
Open Access | Times Cited: 9
Karim Fizazi, Neal D. Shore, Matthew R. Smith, et al.
European Journal of Cancer (2023) Vol. 192, pp. 113258-113258
Open Access | Times Cited: 9
Showing 9 citing articles:
Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patients
Rana R. McKay, Ashley E. Ross, Mark A. Preston, et al.
Future Oncology (2025), pp. 1-11
Open Access
Rana R. McKay, Ashley E. Ross, Mark A. Preston, et al.
Future Oncology (2025), pp. 1-11
Open Access
An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer
Akihiro Matsukawa, Giulio Litterio, Angelo Cormio, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 205-205
Open Access
Akihiro Matsukawa, Giulio Litterio, Angelo Cormio, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 205-205
Open Access
Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review
Nabiel Mir, Olivia Burke, Samuel J. Yates, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 10
Nabiel Mir, Olivia Burke, Samuel J. Yates, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 10
The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies
Rachel Daher, Andrew Ruplin, Shilpa Gupta, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104420-104420
Closed Access | Times Cited: 3
Rachel Daher, Andrew Ruplin, Shilpa Gupta, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104420-104420
Closed Access | Times Cited: 3
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
Eliot B. Blatt, Karla Parra, Antje Neeb, et al.
Oncogene (2023) Vol. 42, Iss. 30, pp. 2347-2359
Closed Access | Times Cited: 7
Eliot B. Blatt, Karla Parra, Antje Neeb, et al.
Oncogene (2023) Vol. 42, Iss. 30, pp. 2347-2359
Closed Access | Times Cited: 7
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models
Urs B. Hagemann, Christoph A. Schatz, Mari I. Suominen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13672-13672
Open Access
Urs B. Hagemann, Christoph A. Schatz, Mari I. Suominen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13672-13672
Open Access
Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol
Paul Sargos, C. Bellera, Rita Bentahila, et al.
European Urology Oncology (2024)
Closed Access
Paul Sargos, C. Bellera, Rita Bentahila, et al.
European Urology Oncology (2024)
Closed Access
Clinical implications of the Drug-Drug interaction in cancer patients treated with innovative oncological treatments
Fiorenza Santamaria, Michela Roberto, Dorelsa Buccilli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104405-104405
Closed Access
Fiorenza Santamaria, Michela Roberto, Dorelsa Buccilli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104405-104405
Closed Access
Safety of solid oncology drugs in older patients: a narrative review
Adrien Rousseau, Arthur Géraud, Romain Geiss, et al.
ESMO Open (2024) Vol. 9, Iss. 11, pp. 103965-103965
Open Access
Adrien Rousseau, Arthur Géraud, Romain Geiss, et al.
ESMO Open (2024) Vol. 9, Iss. 11, pp. 103965-103965
Open Access
